BioNtech, InstaDeep bet on genAI models to advance R&D, drug discovery, cancer treatment
BioNtech's InstaDeep, which was acquired in 2023 for about $682 million, has released a series of foundational generative AI models for proteins and DNA and released them on its DeepChain platform and outlined a supercluster called Kyber.